Tadashi Aoyama

5PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 04, 2018
Addition of bevacizumab to gemcitabine for platinum-resistant recurrent ovarian cancer: a retrospective analysis.

Kazuki Takasaki, Morikazu Miyamoto, Masashi Takano

|Feb 06, 2018
Seromucinous component in endometrioid endometrial carcinoma as a histological predictor of prognosis.

Morikazu Miyamoto, Masashi Takano, Tadashi Aoyama

|Apr 07, 2017
Inhibition of autophagy protein LC3A as a therapeutic target in ovarian clear cell carcinomas.

Morikazu Miyamoto, Masashi Takano, Tadashi Aoyama

Pageof 1